Everus Construction Group, Inc.

Fundamentals7.0
Price Action5.0
News Sentiment7.0
AI Rating
6.0

Key Drivers

  • High ROE/ROIC
  • Thin operating margins
  • Large receivable risk

AI
AI Summary

6.0

ECG has shifted from a cyclical mid-cap into an execution-levered growth story backed by a $3.23B backlog and institutional buying, but its re-rating depends on sustaining margin expansion and reliable conversion of that lumpy backlog. Actionable watch points: monitor quarter-to-quarter E&M margin improvement toward peer levels, receivable days/collections and deferred-revenue normalization, and one or more clean quarters of cash conversion to validate the premium valuation.

GrowthOpportunity
ExecutionRisk
CashFlow‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • High ROE/ROIC
  • Thin operating margins
  • Large receivable risk

ECG delivers strong returns on capital and healthy cash generation despite thin margins, high receivables and elevated valuation multiples.

cashflow
receivables

Price Behavior

5.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Slight uptrend
  • High intraday swings
  • Strong buying near $110

Over the last month ECG eked out a modest ~2.6% gain from $108.16 to $110.95 but remains essentially flat with choppy, high-volatility action—notably a spike to $130.10 then a retracement toward $104—suggesting limited conviction and elevated downside risk.

volatility
mixed
Support Level: $104–$110
Resistance Level: $116–$130 (key breakout >$119–$120)

Spike to $130.10 then rapid retracement toward $104.21 indicating event-driven volatility

Sentiment & News

7.0

Key News Insights:

  • Earnings beat
  • Institutional buying
  • Price momentum

Everus Construction (ECG) has posted a strong Q4/2025 beat with 2026 guidance, sparking analyst upgrades, sizable institutional buying and a sharp share‑price rally into mid‑March 2026.

ECGStrong
Momentum

The combination of upward guidance, analyst upgrades and heavy institutional interest supports near‑term upside for ECG, though mixed trimming by some funds suggests monitoring for potential volatility